Geer Vanden Bossche has been warning that vaccine antibodies would suppress natural antibody responses. The vaccine antibodies take control of the immune system and defend only against a targeted virus.
Antibodies to covid, whether stimulated by a vaccine or by the virus itself, are all antibodies to covid. And they are all made by our immune system.
And they all defend against the spike protein.
This Geer is a stupid idiot.
“Antibodies to covid, whether stimulated by a vaccine or by the virus itself, are all antibodies to covid.”
Your point would be stronger if you didn’t call people stupid. All the US vaccines only target antibodies to the spike protein at rates that are 25x or more higher than natural immunity. Natural immunity provides a balanced response against all 5 proteins. Variants are mutating with the spike. Natural immunity maintains a balanced response and can detects and fight variants better because it detect the other proteins that haven’t changed.
The key question is whether adding the vaccine to natural immunity will in some way diminish the effectiveness of non spike antibodies.
This Geer is a stupid idiot.
~~~~~~~~~~~~~~~~~
Seriously? I suspect he has far more creds than you and perhaps a deeper understanding of infectious diseases, epidemics, and vaccines than a Freeper posting anonymously on a forum board. BTW, he is not anti-vax...He has developed them...
Geert Vanden Bossche (DVM, PhD)
Geert Vanden Bossche received his DVM from the University of Ghent, Belgium, and his PhD degree in Virology from the University of Hohenheim, Germany.
He held adjunct faculty appointments at universities in Belgium and Germany.
After his career in Academia, Geert joined several vaccine companies (GSK Biologicals, Novartis Vaccines, Solvay Biologicals) to serve various roles in vaccine R&D as well as in late vaccine development.
Geert then moved on to join the Bill & Melinda Gates Foundation’s Global Health Discovery team in Seattle (USA) as Senior Program Officer; he then worked with the Global Alliance for Vaccines and Immunization (GAVI) in Geneva as Senior Ebola Program Manager.
At GAVI he tracked efforts to develop an Ebola vaccine. He also represented GAVI in fora with other partners, including WHO, to review progress on the fight against Ebola and to build plans for global pandemic preparedness. Back in 2015, Geert scrutinized and questioned the safety of the Ebola vaccine that was used in ring vaccination trials conducted by WHO in Guinea. His critical scientific analysis and report on the data published by WHO in the Lancet in 2015 was sent to all international health and regulatory authorities involved in the Ebola vaccination program.
After working for GAVI, Geert joined the German Center for Infection Research in Cologne as Head of the Vaccine Development Office.
He is at present primarily serving as a Biotech/ Vaccine consultant while also conducting his own research on Natural Killer cell-based vaccines.